Key result
Bicuspid PTFE membrane valve reconstruction reduces immediate postoperative central venous pressure ~25% versus transannular patch.
Why the study?
Reconstruction of the right ventricular outflow tract during primary repair of tetralogy of Fallot often requires a transannular patch, which results in pulmonary regurgitation.
Does bicuspid polytetrafluoroethylene membrane valve reconstruction improve short-term clinical and echocardiographic outcomes compared to transannular pericardial patch in patients undergoing primary repair of tetralogy of Fallot?
RCT (n=30)
randomly allocated
Does bicuspid polytetrafluoroethylene membrane valve reconstruction improve short-term clinical and echocardiographic outcomes compared to transannular pericardial patch in patients undergoing primary repair of tetralogy of Fallot?
Absolute Event Rate: 7.6% vs 10.13%
p-value: p=0.002
Bicuspid polytetrafluoroethylene membrane valves decrease immediate postoperative central venous pressure, facilitate early extubation, and prevent severe pulmonary regurgitation at 6 months compared to transannular pericardial patch in Tetralogy of Fallot repair.
Supports bicuspid PTFE valve use in TOF repair for faster recovery; extends RCT evidence versus transannular patch.
INTRODUCTION: Reconstruction of right ventricular outflow tract during primary repair of tetralogy of Fallot often requires the placement of a transannular patch which results in pulmonary regurgitation (PR). We compared the short-term outcomes of bicuspid polytetrafluoroethylene membrane valve versus transannular pericardial patch reconstruction of the right ventricular outflow tract. METHODS: Thirty consecutive patients undergoing primary repair of tetralogy of Fallot were randomly allocated to two groups - polytetrafluoroethylene valve (PTFEV) group (n=15) and transannular pericardial patch (TAP) group (n=15). The two groups had similar preoperative demographic characteristics. We compared the short-term clinical and echocardiographic outcomes between these groups. The transthoracic echocardiographic follow-up was performed at one week, one month and six months after surgery. RESULTS: The PTFEV group had significantly lower central venous pressure in the immediate postoperative period compared to the TAP group (7.60±2.06 vs. 10.13±1.73, P=0.002). Extubation time was significantly shorter in the PTFEV group compared to the TAP group (12.93±7.55 hrs vs. 22.23±15.11 hrs, P=0.04). PR in the PTFEV group was absent in five patients at 24 hours post-surgery. At the study endpoint, PR was absent in six, trivial in one and mild in eight patients in the PTFEV group compared to TAP group, where all 15 patients had severe PR. CONCLUSION: The bicuspid polytetrafluoroethylene membrane valves significantly decrease the central venous pressure in the immediate postoperative period, facilitate early extubation and, thus, prevent ventilator-related comorbidities. They achieve a high degree of pulmonary competence and do not increase the right ventricular outflow tract gradient in short-term follow-up.
No takes yet. Share an insight, caveat, or question.
Rawat et al. (2020) conducted an RCT in Tetralogy of Fallot (n=30). Bicuspid polytetrafluoroethylene membrane valve (PTFEV) vs. Transannular pericardial patch (TAP) was evaluated on Central venous pressure in the immediate postoperative period (p=0.002). Bicuspid polytetrafluoroethylene membrane valve reconstruction significantly lowered immediate postoperative central venous pressure compared to transannular patch (7.60 vs 10.13, P=0.002).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: